Antipsychotics - Page 1 | CARLAT PUBLISHING

Expert Q&A

Sleep and Senescence: Managing Sleep Disorders in Older Adults

April 1, 2025

Ellen Lee, MD, Estelle and Edgar Levi Memorial Chair in Aging, Associate Professor, and Chief of Geriatric Psychiatry at the University of California, San Diego; Staff Psychiatrist, San Diego VA Healthcare System, San Diego, CA.

Dr. Lee has no financial relationships with companies related to this material.

Dr. Lee shares her clinical experience on identifying and managing sleep issues as part of aging, including her algorithms to prioritize treatments.

Expert Q&A

Antipsychotics and Weight Gain in Younger Patients

April 1, 2025

Julie Ann Dopheide, PharmD, BCPP, FASHP

Julie Ann Dopheide, PharmD, BCPP, FASHP, Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and Keck School of Medicine, University of Southern California, Los Angeles, CA.
Dr. Dopheide has no financial relationships with companies related to this material.

Audio Issue

Audio Issue, Social and Lifestyle Issues in Child and Adolescent Psychiatry, July/Aug/Sept 2024

March 20, 2025

Joshua Feder, MD

Research Update

A Promising Combo: Olanzapine and Samidorphan

July 1, 2024

Earth Hasassri, MD

Earth Hasassri, MD. Dr. Hasassri has no financial relationships with companies related to this material.

When we must use antipsychotics (NbN D2 receptor blockers), we do whatever we can to avoid side effects from them. This research upside looks at the potential for the new olanzapine-semiglutide combination medication to reduce D2 blocker-related weight gain in children and teens.

Tapering Antipsychotics

February 26, 2024

Joshua Feder, MD and Mara Goverman

Today, we will be discussing the challenges of managing antipsychotic medications in children and adolescents. We will explore various strategies that aim to balance symptom relief with potential side effects, while also guiding towards personalized and safer treatment options. Join us in discovering the art of precision in pediatric mental health care.

Psychopharm Commandments 8A: Polypharmacy Makeover

May 1, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

How to reduce unnecessary polypharmacy, and when it makes sense to keep it going.

Expert Q&A

Pharmacological Treatment of Bipolar Disorder in Older Adults

January 31, 2023

John Beyer, MD

John Beyer, MD. Professor of psychiatry, Duke University Medical Center. Durham, NC. Dr. Beyer has consulted for Express Scripts. Relevant financial relationships listed for the author have been mitigated.

With numerous treatment options available for bipolar depression and mania, clinicians often struggle to navigate between medication classes in balancing side effects, efficacy, and costs. Dr. Beyer shares his expertise in choosing first-, second-, third-, and fourth-line options based on their evidence in older adults.